| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 09/15/2009 | US7589124 Antiinflammatory agents; antipyretics; analgesics; 2,3-bis(nitroxy)-4-(2-(2-((2-chloro-6-fluorophenyl)amino)5-methylphenyl)acetyloxy)butyl 2-(2-((2-chloro-6-fluorophenyl)amino)5-methylphenyl)acetate; gastrointestinal disorders, wound healing, cardiovascular disorders |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7589089 Inhibitors for GlyT-1 |
| 09/15/2009 | US7589081 High degree of activity induced by the ligands in the activation of readily available but inert chloroaromatic compounds; large scale use; N-phenyl-2-(di-1-adamantyl-phosphino)pyrrole |
| 09/15/2009 | CA2385960C Catalysis using phosphine oxide compounds |
| 09/15/2009 | CA2364665C Phenyl- and pyridinyl derivatives |
| 09/11/2009 | WO2009110002A1 Novel efflux pump inhibitors |
| 09/11/2009 | WO2009109648A1 Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| 09/11/2009 | WO2009109222A1 Process for the preparation of rimonabant |
| 09/11/2009 | WO2009015067A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/10/2009 | US20090227791 Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/09/2009 | EP2098518A1 Process for production of highly pure quaternary ammonium salt |
| 09/09/2009 | EP2098511A1 Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| 09/09/2009 | EP2097398A1 Process of producing amorolfine |
| 09/09/2009 | EP1487573B1 Catalysts and method for the production of amines |
| 09/09/2009 | CN100537552C Method for preparing Repaglinide |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585994 used in electrolytes, batteries, capacitors, supercapacitors, and galvanic cells; N,N-dimethylpyrrolidinium trifluoromethanesulfonate; methyl(triethyl)phosphonium trifluoromethanesulfonate |
| 09/08/2009 | US7585977 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585864 1,1-Dimethyl-4-(8-chloro-5,11-dihydro-[1]benzoxepino[4,3-b]pyridin-11(S)-yl)-2(R)-[[[3-(4-methyl-1H-imidazol-1yl)propyl]phenylmethyl)amino]carbonyl]-1-piperazinecarboxylate |
| 09/08/2009 | US7585858 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins |
| 09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
| 09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009078627A3 Method for preparing (r)-(-)-1-[(4-chlorophenyl)phenylmethyl]piperazine |
| 09/03/2009 | US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
| 09/03/2009 | US20090221458 Succinic acid semi-amides as anti-corrosive agents |
| 09/03/2009 | US20090219526 Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2094678A2 Prostaglandin prodrugs as ocular hypotensive agents |
| 09/02/2009 | EP2094633A1 Hydrofluoroeth r compounds and processes for their preparation and use |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | CN101522652A Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 09/02/2009 | CN101522651A Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 09/02/2009 | CN101522650A Method for the continuous separation of mixtures comprising morpholine (MO), monoaminodiglycol (ADG), ammonia, and water by means of distillation |
| 09/02/2009 | CN101522649A Method for the continuous separation of mixtures comprising morpholine (MO), monoaminodiglycol (ADG), ammonia, and water by means of distillation |
| 09/02/2009 | CN101519389A Method for preparing N, N-dimethyl-4-morpholine carboxylic acid amide |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/01/2009 | US7582782 Organic compounds |
| 09/01/2009 | US7582766 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; (N-benzyl)phenylacetamides or N-benzyl-N'-phenyl ureas |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582663 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 09/01/2009 | US7582656 Guanidine derivatives and therapeutic uses thereof |
| 09/01/2009 | US7582653 Mercaptophenyl naphthyl methane compounds and synthesis thereof |
| 09/01/2009 | US7582639 Thiocolchicine dimers linked through linear aliphatic amido or amido-ureido bridge; antiproliferative, antiinflammatory, antiarthritic, antiviral agents; cytotoxicity; piperazinedicarboxylic acid bis-(N-deacetylthiocolchicine) amide derivatives; acts on cells expressing multidrug resistant phenotypes |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 09/01/2009 | CA2376691C Antipsychotic cyclic n-aralkylamines |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 08/27/2009 | WO2009105435A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/27/2009 | WO2009105257A1 Compounds for treating proliferative disorders |
| 08/27/2009 | WO2009104058A1 Tritium radiolabeling of [3h]-1-cyclohexyl-4-[3-(5-methoxy-1,2, 3,4,-tetrahydronaphthalen-1-yl)-n-propyl]piperazine ([3h]-pb28), as a potent sigma-2 receptor ligand |
| 08/27/2009 | WO2008116145A3 Soluble epoxide hydrolase inhibitors |
| 08/27/2009 | WO2007079003A3 Amide inhibitors of leukotriene a4 hydrolase |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215780 Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity |
| 08/27/2009 | CA2715557A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/26/2009 | EP2091930A1 Crosslinker for vulcanization, process for its preparation and rubber products |
| 08/26/2009 | EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 08/26/2009 | EP2091915A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | CN101516862A Process for production of highly pure quaternary ammonium salt |
| 08/26/2009 | CN101516838A Soluble epoxide hydrolase inhibitors |
| 08/26/2009 | CN101516830A Method for the continuous separation by distillation of mixtures that contain morpholine (mo), monoaminodiglycol (adg), ammonia and water |
| 08/26/2009 | CN101516826A Beta-3 receptor ligands and their use in therapy |
| 08/26/2009 | CN101516361A Soluble epoxide hydrolase inhibitors |
| 08/26/2009 | CN100531732C Thiomolybdate analogues |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579467 N-phenyl-2-pyrimidine-amine derivatives |
| 08/25/2009 | US7579462 Reacting allyl amine and geldanamycin in volatile aprotic solvent (tetrahydrofuran), concentrating by evaporation, adding volatile protic solvent (iisopropanol), removing protic solvent to purify, then filtering; making 17-allylamino-geldanamycin (Tanespimycin) |
| 08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/20/2009 | WO2009071668A3 Piperazine derivatives and their use as leptin receptor modulators |
| 08/20/2009 | US20090209593 Novel antibacterial agents |
| 08/20/2009 | US20090209520 2 -oxybenzamide derivatives as parp inhibitors |
| 08/20/2009 | US20090209514 Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists |
| 08/19/2009 | EP2090565A2 Ionic liquids |
| 08/19/2009 | EP1799665B1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid |
| 08/19/2009 | EP1546119B1 Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 08/19/2009 | EP1513802B1 Alpha-sulfonylamino-acetonitriles |
| 08/19/2009 | CN101511807A Substituted benzamide modulators of the histamine H3 receptor |
| 08/19/2009 | CN101511806A New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment |
| 08/19/2009 | CN101511805A Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands |
| 08/19/2009 | CN101511791A Piperazinyl derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 08/19/2009 | CN101511790A Substituted aminomethyl benzamide compounds |
| 08/19/2009 | CN101511785A Substituted benzyl amine compounds |
| 08/19/2009 | CN101511775A Butyl and butynyl benzyl amine compounds |
| 08/19/2009 | CN101508685A Improved preparation method for cinepazide maleate |
| 08/19/2009 | CN101508684A Synthesis of cinepazide maleate |
| 08/19/2009 | CN101508683A Dehydrogenation ammoniation method for producing pyrrolidine with 1,4butanediol |
| 08/19/2009 | CN100528853C Method for the synthesis of exocyclic derivatives of cycloalkyl-hydrazines and exocyclic derivatives of heterocycloalkyl-hydrazines |
| 08/19/2009 | CN100528852C Piperazine-based sensitisers |